Short Interest in Guardion Health Sciences, Inc. (NASDAQ:GHSI) Grows By 45.7%

Guardion Health Sciences, Inc. (NASDAQ:GHSI) was the recipient of a large growth in short interest during the month of August. As of August 31st, there was short interest totalling 81,000 shares, a growth of 45.7% from the August 15th total of 55,600 shares. Currently, 6.4% of the company’s stock are short sold. Based on an average daily trading volume, of 81,100 shares, the short-interest ratio is currently 1.0 days.

Guardion Health Sciences Price Performance

Shares of NASDAQ:GHSI opened at $9.91 on Monday. Guardion Health Sciences has a 12 month low of $5.01 and a 12 month high of $18.00. The firm has a market capitalization of $12.72 million, a P/E ratio of -2.47 and a beta of 0.80. The company’s fifty day moving average price is $10.57 and its 200 day moving average price is $9.45.

Guardion Health Sciences (NASDAQ:GHSI) last posted its earnings results on Tuesday, August 13th. The company reported ($1.64) EPS for the quarter. Guardion Health Sciences had a negative return on equity of 73.69% and a net margin of 22.79%. The firm had revenue of $0.07 million for the quarter.

Guardion Health Sciences Dividend Announcement

The company also recently declared a dividend, which will be paid on Monday, September 23rd. Shareholders of record on Monday, September 9th will be given a dividend of $5.00 per share. The ex-dividend date of this dividend is Tuesday, September 24th. Guardion Health Sciences’s dividend payout ratio (DPR) is -124.38%.

Guardion Health Sciences Company Profile

Guardion Health Sciences, Inc, a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment.